CDT Equity Inc. (Nasdaq: CDT), an SEC filer in Pharmaceutical Preparations, closed at $1.69, -10.1%, on 2026-08-28, with a market cap of $1M as of 2026-08-27. Institutional ownership, earnings history and filed financials are on the tabs below.
| Market Cap | $1.3M | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | -$37.1M | — |
| Diluted EPS | — | — |
| Free Cash Flow | -$11.9M | — |
Bars are the value as filed for every stored fiscal year (oldest → newest, the latest bar solid); a year the store has no value for is left EMPTY. Free cash flow is operating cash flow less capital expenditures for the same year — the only figure here computed from two lines, and a year missing either one is a gap. The 3y/5y/10y CAGRs are the analytics core’s own (positive-base only); no rate is recomputed on this strip, and no rate is shown for a series the core doesn’t publish one for. Diluted EPS is drawn on ONE share basis: as-filed per-share figures from before a split are stated on the old basis, so where the implied share count breaks (net income ÷ EPS, ±1.45× band — the same acceptance band the API’s own classifier uses) the earlier bars are left undrawn and any CAGR horizon reaching past the break is suppressed rather than shown as a rate across two different bases.
Every bar is a figure as filed. Anything a filed line doesn’t explain is drawn as a residual, never absorbed into a neighbouring step.
This filer skips: revenue, gross profit.
Reconciliation.
| Step | Applied | Running level | share | 2024 |
|---|---|---|---|---|
| Operating income · reported | -$36.8M | -$36.8M | — | -$15.4M |
| Interest expense | -$200,000 | -$37.0M | — | $32,000 |
| Other non-operating | -$2.2M | -$39.1M | — | $890,000 |
| Other (residual) · residual | -$91,000 | -$39.2M | — | — |
| Pretax income · reported | -$39.2M | -$39.2M | — | -$17.8M |
| Net income · reported | -$39.2M | -$39.2M | — | -$17.8M |
Cumulative operating cash flow over FY2022–FY2025 is -$35.2M — not positive, so there is no operating-cash pool to allocate and no bridge is drawn. Lenders and other balance-sheet businesses routinely report negative operating cash flow (loan originations run through it); read the cash-flow statement directly below.
| Line | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|
| R&D Expense | $37,000 | $90,000 | $3.4M | $5.1M |
| YoY % | +143.2% | +3653.3% | +49.6% | |
| SG&A Expense | $3.0M | $5.2M | $12.0M | $31.7M |
| YoY % | +69.6% | +132.8% | +163.3% | |
| Total Operating Expenses | $3.2M | $5.3M | $15.4M | $36.8M |
| YoY % | +66.5% | +193.0% | +138.4% | |
| Operating Income | -$3.2M | -$5.3M | -$15.4M | -$36.8M |
| Interest Expense | $100,000 | — | $32,000 | $200,000 |
| YoY % | +525.0% | |||
| Interest & Investment Income | $2.0M | $15,000 | — | — |
| YoY % | -99.2% | |||
| Other Non-Operating Income | -$1.7M | $4.9M | -$890,000 | -$2.2M |
| Pretax Income | $773,501 | -$536,000 | -$17.8M | -$39.2M |
| Income Tax | $374,862 | — | — | — |
| Net Income | -$4.9M | -$535,000 | -$17.8M | -$39.2M |
| Net Income to Common | -$4.9M | -$535,000 | -$17.8M | -$39.2M |
| EPS (Basic) | -$0.13 | -$0.79 | -$20.53 | -$1177.89 |
| EPS (Diluted) | -$0.13 | -$8.92 | -$20.53 | -$1177.89 |
| Weighted Avg Shares (Basic) | 37.4M | 669,739 | 867,096 | 33,300 |
| YoY % | -98.2% | +29.5% | -96.2% | |
| Weighted Avg Shares (Diluted) | 37.4M | 678,939 | 867,096 | 33,300 |
| YoY % | -98.2% | +27.7% | -96.2% |
Sector is SIC-based, not GICS. A blank cell means the figure wasn't filed.
